Disclaimer
BCS Capital (DIFC) Limited (also trading as The Ultima World. Wealth Management Platform), hereinafter referred to as BCS, is authorized and regulated by Dubai Financial Services Authority (DFSA) with DIFC license number CL3568, DFSA reference number F004980. Address: Unit 1002 Level 10, Index Tower, Dubai International Financial Centre, Dubai, P.O. Box 507341, United Arab Emirates.
BCS has a license from the DFSA authorizing it to engage in the following regulated activities in or from the DIFC: Advising on Financial products, Arranging Custody, Arranging Deals in Investments, Dealing in Investments as Agent and Managing Assets, with both an Endorsement to deal with Retail Clients & to Hold or Control Client Assets.
Please, note that past performance is not necessarily a reliable indicator of future results.
The information presented at this website shall not be treated as a public offer, solicitation or invitation to buy or sell any securities, financial instruments or services. BCS reserves the right to make the final decision on whether to provide the products and / or services to a particular client, as well as whether to refuse to provide products and / or services. No representations or warranties, explicit or implied, including imposed by law, in connection with the data and information provided, are given. None part of the information shall be regarded as a recommendation to invest funds, nor a guarantee or a promise of future return on investments.
Retail Clients looking to invest in OTC Derivative financial instruments should be aware of a number of associated risks. There is a risk that a small movement in the market may lead to a much larger movement in the value of your investment and this could work to your disadvantage or advantage. Please refer to Company’s OTC Derivatives Risk Disclosure Statement for more information, including on existing conflict of interests and the percentage of profitable retail clients in four of the most recent calendar quarters.
OTC DERIVATIVES RISK DISCLOSURE STATEMENT
OTC DERIVATIVES RISK DISCLOSURE STATEMENT. EFFECTIVE 31 JULY 2024